TP53 and neoplasm: By inhibiting the tumour suppressor proteins p21 and p53, CDK4 up-regulation promotes a cellular microenvironment that is more conducive to oncogenesis, allowing damaged cells or cellular DNA to segregate and produce more tumour cells that escape cell cycle checkpoints [1].